Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Summit Therapeutics (SMMT) Return on Sales: 2017-2024

Historic Return on Sales for Summit Therapeutics (SMMT) over the last 2 years, with Dec 2024 value amounting to 21.09%.

  • Summit Therapeutics' Return on Sales was N/A to 21.09% in Q4 2024 from the same period last year, while for Dec 2024 it was 21.09%, marking a year-over-year change of. This contributed to the annual value of 27.02% for FY2024, which is 1276.00% down from last year.
  • Summit Therapeutics' Return on Sales amounted to 21.09% in Q4 2024, which was up 29.38% from 16.30% recorded in Q3 2024.
  • Over the past 5 years, Summit Therapeutics' Return on Sales peaked at 21.09% during Q4 2024, and registered a low of -22.87% during Q3 2022.
  • In the last 2 years, Summit Therapeutics' Return on Sales had a median value of 16.30% in 2024 and averaged 4.84%.
  • Data for Summit Therapeutics' Return on Sales shows a maximum YoY plummeted of 1,341bps (in 2020) over the last 5 years.
  • Summit Therapeutics' Return on Sales (Quarterly) stood at -12.95% in 2020, then followed by -22.87% in 2022, then followed by 21.09% in 2024.
  • Its Return on Sales stands at 21.09% for Q4 2024, versus 16.30% for Q3 2024 and -22.87% for Q3 2022.